Concourse Financial Group Securities, Inc. Exagen Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
25 transactions
Others Institutions Holding XGN
# of Institutions
56Shares Held
8.95MCall Options Held
0Put Options Held
0-
Rtw Investments, LP New York, NY1.7MShares$15.7 Million0.18% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6851KShares$7.87 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA734KShares$6.79 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL719KShares$6.65 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$4.92 Million0.03% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $150M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...